Physician profile
Joseph Sciortino
NPI 1942947650
$1,084.24
in general payments reported to CMS, 2019-2025
10 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $71.99 · 2023: $304 · 2024: $273 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $339.74 | 2023-2025 | Infuse |
| Alcon Vision LLC | $231.73 | 2022-2025 | Clareon Panoptix Pro, Precision 1, Precision7 |
| Lkc Technologies, INC. | $117.13 | 2025 | |
| Dompe US, INC. | $89.58 | 2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $86.20 | 2023 | Cequa |
| Oyster Point Pharma, INC. | $60.95 | 2023-2024 | Tyrvaya |
| Coopervision INC. | $60.52 | 2023-2025 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $49.86 | 2024 | |
| Biotissue Holdings INC. | $32.10 | 2022 | |
| Abb Con-Cise Optical Group LLC | $16.43 | 2023 | Contact Lens, Spectacle Lenses |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Sciortino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.